Dorche G, Lucht F, Bertrand A M, Vinhas E, Gibaud H, Aubert G, Brunon J
Services de Bactériologie, Hôpital Bellevue, CHRU Saint-Etienne, France.
Pathol Biol (Paris). 1990 Jun;38(6):638-42.
Study of the penetration of ceftriaxone into the brain of patients who underwent surgery for cerebral tumors. Seventeen patients received 2 g of ceftriaxone intravenously 2 h to 13 h before blood and brain samples were taken. Ceftriaxone levels in serum and in non tumoral cerebral tissue were determined by the agar well diffusion technique. Hemoglobin concentration was measured in cerebral samples in order to subtract ceftriaxone due to blood contamination. True ceftriaxone levels in cerebral tissue ranged from 0.3 to 12 mcg/g, mean 1.63 mcg/g. The ceftriaxone level ratio in brain and serum was low, mean about 2%, but cerebral ceftriaxone concentrations would be sufficient to inhibit more than 75% of bacteria isolated in recent cerebral abscesses. These results allow to do further therapeutic studies of ceftriaxone in cerebral abscesses due to identified and susceptible bacteria or in random treatment in association with antibiotics directed on anaerobic organisms and resistant hospital strains.
头孢曲松在接受脑肿瘤手术患者脑内渗透性的研究。17例患者在采集血液和脑样本前2小时至13小时静脉注射2克头孢曲松。血清和非肿瘤性脑组织中的头孢曲松水平通过琼脂孔扩散技术测定。在脑样本中测量血红蛋白浓度,以便减去因血液污染而产生的头孢曲松。脑组织中真正的头孢曲松水平范围为0.3至12微克/克,平均为1.63微克/克。脑和血清中的头孢曲松水平比值较低,平均约为2%,但脑内头孢曲松浓度足以抑制近期脑脓肿中分离出的75%以上的细菌。这些结果有助于对头孢曲松在由已鉴定且敏感细菌引起的脑脓肿中的进一步治疗研究,或与针对厌氧菌和耐药医院菌株的抗生素联合进行随机治疗研究。